Invega associated with Diabetic Ketoacidosis

By Rheingold Giuffra Ruffo & Plotkin LLP

Invega associated with Diabetic Ketoacidosis

Invega, or Paliperidone, is an antipsychotic medication manufactured by Janssen Pharmaceuticals under Johnson and Johnson. It works by altering the effects of chemicals in the brain, although the exact chemical pathway is unknown. It is proven to be effective for patients with schizophrenia or schizoaffective related disorder.

Invega can cause a serious side effect of diabetic ketoacidosis. Some patients who took Invega have developed diabetic ketoacidosis as a result of the drug when they had no prior case of diabetes. Invega may also cause imbalances in hormones that leads to an overexpression of the hormone prolactin, resulting in excess tissue in the breast region, known as gynecomastia.

Other common side effects include: drowsiness, dizziness, lightheadedness, drooling, stomach/abdominal pain, weight gain, tiredness, agitation/feeling restless, tremors/shaking, uncontrolled muscle movements/problems with balance or walking, upset stomach/constipation, neck stiffness, and fast heart rate.

If you or someone you know has suffered from ketacidosis as a result of taking Invega, call the drug liability attorneys at Rheingold, Giuffra, Ruffo & Plotkin LLP, to protect your rights: (212) 684-1880.

Related Posts

What Is Autism?

Recent studies show that Tylenol is related to autism diagnosis in adolescents. These studies have brought about new litigation involving Tylenol and acetaminophen and its alleged effects

View Article